Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues
- 1 September 1999
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 354 (9184), 1084-1089
- https://doi.org/10.1016/s0140-6736(99)07219-0
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Adverse effects of reverse transcriptase inhibitorsAIDS, 1998
- The British Paediatric Surveillance Unit — a pioneering method for investigating the less common disorders of childhood. Report of a seminar held in June 1995Child: Care, Health and Development, 1998
- Mitochondrial Mutations and Hearing Loss: Paradigm for Mitochondrial GeneticsAmerican Journal of Human Genetics, 1998
- A Risk-Benefit Assessment of Zidovudine in the Prevention of Perinatal HIV TransmissionDrug Safety, 1995
- Valproate and cytochromec oxidase deficiencyEuropean Journal of Pediatrics, 1995
- Zidovudine for mother, fetus, and child: hope or poison?The Lancet, 1994
- Biochemical and molecular investigations in respiratory chain deficienciesClinica Chimica Acta; International Journal of Clinical Chemistry, 1994
- Assessment of the mitochondrial respiratory chainThe Lancet, 1991
- Mitochondrial Myopathy Caused by Long-Term Zidovudine TherapyNew England Journal of Medicine, 1990
- A Prospective Study of Infants Born to Women Seropositive for Human Immunodeficiency Virus Type 1New England Journal of Medicine, 1989